OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Sandra Black

1 Projects | 1 Researchers | $992,388 Invested

2012

Sunnybrook Research Institute

Sandra Black, MD, FRCP(C)

Sartans to Slow Alzheimer's Disease: A Randomized, Open-Label, Head-to-Head, Proof-of-Concept Study of Angiotensin Receptor Blockers Versus ACE Inhibitors in Hypertensive Mild-Moderate AD Patients using Ventricular Enlargement as Primary Outcome

  • Funding Amount: $992,388
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Vascular
  • Status: Closed